|
1.
|
ter Borg EJ, Horst G, Hummel EJ, Limburg
PC and Kallenberg CG: Measurement of increases in
anti-double-stranded DNA antibody levels as a predictor of disease
exacerbation in systemic lupus erythematosus. A long-term,
prospective study. Arthritis Rheum. 33:634–643. 1990.
|
|
2.
|
Verstegen G, Duyck MC, Meeus P,
Ravelingien I and De Vlam K: Detection and identification of
antinuclear antibodies (ANA) in a large community hospital. Acta
Clin Belg. 64:317–323. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
3.
|
Peene I, Meheus L, Veys EM and De Keyser
F: Detection and identification of antinuclear antibodies (ANA) in
a large and consecutive cohort of serum samples referred for ANA
testing. Ann Rheum Dis. 60:1131–1136. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
4.
|
Riemekasten G, Marell J, Trebeljahr G, et
al: A novel epitope on the C-terminus of SmD1 is recognized by the
majority of sera from patients with systemic lupus erythematosus. J
Clin Invest. 102:754–763. 1998. View
Article : Google Scholar : PubMed/NCBI
|
|
5.
|
Zhang YF and Zheng Y: Significance of
detection of anti-SmD1 antibody in systemic lupus erythematosus.
Chinese Journal of Rheumatology. 1l:397–401. 2007.
|
|
6.
|
Wang BF, Chen XG, Wang ZZ, Liu CY, Zeng QD
and Du TX: Clinical significance of determination of serum
anti-SmD1 antibody in patients with SLE. J Radioimmunol.
21:490–492. 2008.
|
|
7.
|
Jeoung D, Lim Y, Lee EB, et al:
Identification of autoantibody against poly (ADP-ribose) polymerase
(PARP) fragment as a serological marker in systemic lupus
erythematosus. J Autoimmun. 22:87–94. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
8.
|
Servais G, Guillaume MP, Dumarey N and
Duchateau J: Evidence of autoantibodies to cell membrane associated
DNA (cultured lymphocytes): a new specific marker for rapid
identification of systemic lupus erythematosus. Ann Rheum Dis.
57:606–613. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
9.
|
Chen HY, Jia RL and Li ZG: Significance of
anti-cell membrane associated DNA (mDNA) antibodies in systemic
lupus erythematosus. Chinese Journal of Rheumatology. 9:229–233.
2005.PubMed/NCBI
|
|
10.
|
Guo JL, Bi LQ and Li ZG: Significance of
anti-cell membrane associated DNA antibodies in diagnosis of
systemic lupus erythematosus lacking of specific autoantibodies.
Chinese Journal of Laboratory Medicine. 29:787–790. 2006.
|
|
11.
|
Tang F, Dong Y and Zhang N: Detection of
anti-SSB antibodies in patients with rheumatic diseases. Chin Med
Sci J. 8:55–58. 1993.PubMed/NCBI
|
|
12.
|
Hsieh SC, Yu HS, Lin WW, et al:
Anti-SSB/La is one of the antineutrophil autoantibodies responsible
for neutropenia and functional impairment of polymorphonuclear
neutrophils in patients with systemic lupus erythematosus. Clin Exp
Immunol. 131:506–516. 2003. View Article : Google Scholar
|
|
13.
|
Peene I, Meheus L, Veys EM and De Keyser
F: Diagnostic associations in a large and consecutively identified
population positive for anti-SSA and/or anti-SSB: the range of
associated diseases differs according to the detailed serotype. Ann
Rheum Dis. 61:1090–1094. 2002. View Article : Google Scholar
|
|
14.
|
Arbuckle MR, McClain MT, Rubertone MV, et
al: Development of autoantibodies before the clinical onset of
systemic lupus erythematosus. N Engl J Med. 349:1526–1533. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
15.
|
No authors listed. Guidelines for referral
and management of systemic lupus erythematosus in adults. American
College of Rheumatology Ad Hoc Committee on Systemic Lupus
Erythematosus Guidelines. Arthritis Rheum. 42:1785–1796. 1999.
View Article : Google Scholar : PubMed/NCBI
|
|
16.
|
Bombardier C, Gladman DD, Urowitz MB,
Caron D and Chang CH: Derivation of the SLEDAI. A disease activity
index for lupus patients The Committee on Prognosis Studies in SLE.
Arthritis Rheum. 35:630–640. 1992. View Article : Google Scholar : PubMed/NCBI
|
|
17.
|
Alspaugh M and Maddison P: Resolution of
the identity of certain antigen-antibody systems in systemic lupus
erythematosus and Sjögren’s syndrome: an interlaboratory
collaboration. Arthritis Rheum. 22:796–798. 1979.PubMed/NCBI
|
|
18.
|
Biswas D, Mathias A, Dayal R, Aggarwal A,
Misra R and Naik S: Presence of antibodies to SSB/La is associated
with decreased phagocytic efficiency of neutrophils in patients
with systemic lupus erythematosus. Clin Rheumatol. 27:717–722.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
19.
|
Deng A, Zhong R, Chen S and Kong X:
Sequence analysis of autoantigen SS-B/La. Chinese Journal of
Immunology. 16:471–473. 2000.
|
|
20.
|
Pourmand N, Wahren-Herlenius M, Gunnarsson
I, et al: Ro/SSA and La/SSB specific IgA autoantibodies in serum of
patients with Sjögren’s syndrome and systemic lupus erythematosus.
Ann Rheum Dis. 58:623–629. 1999.PubMed/NCBI
|
|
21.
|
Routsias JG and Tzioufas AG: B-cell
epitopes of the intracellular autoantigens Ro/SSA and La/SSB: tools
to study the regulation of the autoimmune response. J Autoimmun.
35:256–264. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
22.
|
Routsias JG, Touloupi E, Dotsika E, et al:
Unmasking the anti-La/SSB response in sera from patients with
Sjögren’s syndrome by specific blocking of anti-idiotypic
antibodies to La/SSB antigenic determinants. Mol Med. 8:293–305.
2002.PubMed/NCBI
|
|
23.
|
Routsias JG, Dotsika E, Touloupi E, et al:
Idiotype-anti-idiotype circuit in non-autoimmune mice after
immunization with the epitope and complementary epitope 289–308aa
of La/SSB: implications for the maintenance and perpetuation of the
anti-La/SSB response. J Autoimmun. 21:17–26. 2003.PubMed/NCBI
|
|
24.
|
Barcellos KS, Nonogaki S, Enokihara MM,
Teixeira MS and Andrade LE: Differential expression of Ro/SSA 60
kDa and La/SSB, but not Ro/SSA 52 kDa, mRNA and protein in minor
salivary glands from patients with primary Sjögren’s syndrome. J
Rheumatol. 34:1283–1292. 2007.PubMed/NCBI
|
